Acumen Pharmaceuticals Inc (ABOS) Insider Trading

Total insider buys:
  • $45,559,997.50
Total insider sells:
  • $382,384.76
Most recent insider trade:
  • Jan. 19, 2024
Most active insider trader:
  • Derek M Meisner
Trader NameDateTitleAmountPriceTypeTotal Value
Jan. 19, 2024Insider8,933$3.48Sell$31,086.84
Jan. 19, 2024CEO15,200$3.47Sell$52,744.00
Jan. 18, 2024CFO4,242$3.71Sell$15,737.82
Jan. 18, 2024COO2,833$3.73Sell$10,567.09
Aug. 17, 2023Director41,949$6.49Sell$272,249.01
July 21, 2023Director5,161,290$7.75Buy$39,999,997.50
July 6, 2021Major Shareholder312,500$16.00Buy$5,000,000.00
July 6, 2021Director35,000$16.00Buy$560,000.00
First«1 of 1»Last
  • Insiders are both buying and selling Acumen Pharmaceuticals Inc stock.

  • The insider traders at Acumen Pharmaceuticals Inc are: Daniel Joseph Oconnell, Derek M Meisner, Jeffrey L. Ives, John A Stalfort III, Matt Zuga, Paul B Manning, Ra Capital Management, L.P., and Russell Barton

  • The most active insider trader at Acumen Pharmaceuticals Inc is Daniel Joseph Oconnell with 1 trades.

  • Jeffrey L. Ives has sold the most Acumen Pharmaceuticals Inc stock with a total value of $544,498.02.

  • Ra Capital Management, L.P. has bought the most Acumen Pharmaceuticals Inc stock with a total value of $79,999,995.00.

  • The most recent insider trade for Acumen Pharmaceuticals Inc was on Jan. 19, 2024.

  • The single biggest insider buy for Acumen Pharmaceuticals Inc was from Ra Capital Management, L.P. with a total value of $39,999,997.50 on July 21, 2023.

  • The single biggest insider sell for Acumen Pharmaceuticals Inc was from Jeffrey L. Ives with a total value of $272,249.01 on Aug. 17, 2023.